Price Chart

Profile

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.
URL https://www.coherus.com
Investor Relations URL https://investors.coherus.com
HQ State/Province California
Sector Health Care
Industry Biotechnology
Next Earnings Release May. 09, 2025 (est.)
Last Earnings Release Mar. 10, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.
URL https://www.coherus.com
Investor Relations URL https://investors.coherus.com
HQ State/Province California
Sector Health Care
Industry Biotechnology
Next Earnings Release May. 09, 2025 (est.)
Last Earnings Release Mar. 10, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A